Author:
Postma Doerine J.,De Smet Peter A. G. M.,Notenboom Kim,Leufkens Hubert G. M.,Mantel-Teeuwisse Aukje K.
Abstract
Abstract
Background
Medicine shortages are often described in plain numbers, suggesting all shortages have a uniform impact. However, some shortages have a direct and serious effect on patients and need a prompt reaction from stakeholders. This study aims to create a broad framework to assess the impact of a shortage.
Method
We identified high impact shortages and selected exemplary shortages which we considered our learning cases. From five learning cases, we identified elements that had a potentially profound impact on one or more of these cases. We tested data saturation on the elements with another five test cases. Based on these elements, we created a framework to assess impact of shortages on patients and presented practical examples how to rate these different elements. Subsequently, we visualised the impact of these five learning cases on patients in radar charts.
Results
The five elements which we identified as potentially having a large impact were 1) alternative product, 2) disease, 3) susceptibility, 4) costs and 5) number of patients affected. The five learning cases rated high on different elements, leading to diverse and sometimes even opposite patterns of impact.
Conclusion
We created a framework for assessing the impact of a medicine shortage on patients by means of five key elements. By rating these elements, an indication of the impact can be obtained.
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. World Health Organization. Medicines shortages: global approaches to addressing shortages of essential medicines in health systems. WHO Drug Information. 2016;30(2):180–5.
2. World Health Organization. Addressing the global shortage of, and access to, medicines and vaccines. Report by the Director-General. 2018. http://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_12-en.pdf. Accessed: 15 Sept 2022.
3. Mehta B, Salmon J, Ibrahim S. Potential shortages of hydroxychloroquine for patients with lupus during the coronavirus disease 2019 pandemic. JAMA Health Forum. 2020;1(4):e200438–8.
4. Choo EK, Rajkumar SV. Medication shortages during the COVID-19 crisis: what we must do. Mayo Clin Proc. 2020;95(6):1112–5.
5. Chatterjee P. Indian pharma threatened by COVID-19 shutdowns in China. Lancet. 2020;395(10225):675.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献